Chou William — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Chou William is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $75K.
Profile
William Chou is the President and Chief Executive Officer of Passage Bio, Inc., a genetic medicines company focused on rare monogenic CNS disorders. This is based on the SEC filing context (CIK 0001949693) with the most recent filing dated 2026-01-12, which lists him in the top executive role and shows no equity purchases or sales in that period.
Role
Insider
Notability
42/100
Board memberships
Passage Bio, Inc.
Awards & honors
Leading Passage Bio as CEO and overseeing strategic direction for a pipeline of genetic medicines targeting rare CNS disorders.
William Chou is the President and Chief Executive Officer of Passage Bio, Inc., a genetic medicines company focused on rare monogenic CNS disorders. This is based on the SEC filing context (CIK 0001949693) with the most recent filing dated 2026-01-12, which lists him in the top executive role and shows no equity purchases or sales in that period.…
Has Chou William been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($75K) across all tracked filings.
Where can I see all of Chou William's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
